Skip to main content
SpringerLink
Log in

Refraktäre oder rezidivierende diffus großzellige B-Zelllymphome

Anti-CD19-CAR-T-Zellen zur Behandlung des refraktären oder rezidivierenden DLBCL

  • journal club
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Crump M et al. Blood. 2017;130(16):1800–8

    Article  CAS  Google Scholar 

  2. Schuster SJ et al. N Engl J Med. 2019;380(1):45–56

    Article  CAS  Google Scholar 

  3. Neelapu SS et al. N Engl J Med. 2017;377(26):2531–44

    Article  CAS  Google Scholar 

Literatur

  • Schuster SJ et al. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma. N Engl J Med. 2019;380(1):45–56

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinischen Pharmakologie am Klinikum der Universität München, München, Deutschland

    Sebastian Kobold (Oberarzt)

Authors
  1. Sebastian Kobold
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastian Kobold.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kobold, S. Anti-CD19-CAR-T-Zellen zur Behandlung des refraktären oder rezidivierenden DLBCL. Info Onkol. 22, 31–32 (2019). https://doi.org/10.1007/s15004-019-6554-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-019-6554-5

Search

Navigation